Home Services Europe & Asia

Europe & Asia

In country  services


Experience via our US staff, or working with our European and Asian partners / contract consultants, our reach extends globally.


Synergy is focused on providing foreign pharmaceutical companies with the
services they need to successfully enter the U.S. market.  In effect, Synergy
serves as "in-country caretaker" for its foreign customers.  Synergy Research
can assist with regulatory affairs, clinical research including  pre-clinical through
regulatory approval, and creating a market presence in the United States.  
This concept has helped many startup firms secure funding to further the
R&D effort.

"By using Synergy Research as their local operations, Synergy Research's clients
will be able to create their own stable presence in the U.S. market with minimal
investment" explains Mario Guralnik, Chief Executive Officer, Synergy Research.
"We can help them meet the challenges of moving from a 'virtual' to a 'brick and
mortar' company with a presence in the United States."

Synergy Research's New Jersey facility provides an ideal location to the
pharmaceutical industry and Wall Street.  It also allows access to its employees'
broad range of skills, industry contacts and experience to develop pharmaceutical
products for foreign firms.

News & Events

  • Pending Litigation to Delay Launch of Generic Asacol Boehringer Ingelheim’s Roxane Laboratori... Read more>>
  • AllTranz Developing Multi-Use Transdermal Patch   AllTranz, Lexington, Ky., is focused on t... Read more>>
  • Food and Drug Administration NOTICES Meetings:   Internationa... Read more>>
  • GSK Receives EMEA Approval for Duodart LONDON (AP) - Pharmaceutical company GlaxoSmithKline... Read more>>
  • in vivo Pharmacodynamic Assay Trevigen offers a validated assay with higher sensitivity and... Read more>>
  • New Class of Brain-Protecting Drugs Emerging Researchers have identified a compound that mim... Read more>>
  • FDA Says Additional Pixuvri Trial Needed, CTI Opens Drug to Expanded Access Cell Therapeutics... Read more>>
  • Novozymes Partnering With ProMetic Life Sciences Inc.Drug Discovery & Development - April 0... Read more>>
  • Statins May Slow Progression Of Multiple Sclerosis, New Study Finds A UCSF-led study exa... Read more>>
  • T Cell Proliferation Assays ProImmune Ltd, a leader in epitope discovery, immunogenicity, an... Read more>>
  • FDA Requests More Information on Certriad LONDON (AP) - AstraZeneca PLC and Abbott Laborator... Read more>>
  • Proximagen Signs Deal With Upsher-Smith Proximagen Neuroscience plc, a biotechnology company... Read more>>